| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Histogen Inc (F: CPH1)
CPH1 Technical Analysis
5
| As on 2nd Jun 2022 CPH1 STOCK Price closed @ 0.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.84 & Strong Sell for SHORT-TERM with Stoploss of 1.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CPH1STOCK Price
| Open | 0.09 | Change | Price | % |
| High | 0.09 | 1 Day | -0.04 | -30.77 |
| Low | 0.09 | 1 Week | -0.05 | -35.71 |
| Close | 0.09 | 1 Month | -0.09 | -50.00 |
| Volume | 11150 | 1 Year | -1.11 | -92.50 |
| 52 Week High 1.51 | 52 Week Low 0.13 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| CPH1 Daily Charts |
CPH1 Intraday Charts |
Whats New @ Bazaartrend |
CPH1 Free Analysis |
|
|
CPH1 Important Levels Intraday
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.09 |
CPH1 Forecast December 2024
| 4th UP Forecast | 1.48 |
| 3rd UP Forecast | 1.03 |
| 2nd UP Forecast | 0.76 |
| 1st UP Forecast | 0.48 |
| 1st DOWN Forecast | -0.3 |
| 2nd DOWN Forecast | -0.58 |
| 3rd DOWN Forecast | -0.85 |
| 4th DOWN Forecast | -1.3 |
CPH1 Weekly Forecast
| 4th UP Forecast | 0.38 |
| 3rd UP Forecast | 0.29 |
| 2nd UP Forecast | 0.23 |
| 1st UP Forecast | 0.17 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.11 |
| 4th DOWN Forecast | -0.20 |
CPH1 Forecast2024
| 4th UP Forecast | 3 |
| 3rd UP Forecast | 2.07 |
| 2nd UP Forecast | 1.49 |
| 1st UP Forecast | 0.91 |
| 1st DOWN Forecast | -0.73 |
| 2nd DOWN Forecast | -1.31 |
| 3rd DOWN Forecast | -1.89 |
| 4th DOWN Forecast | -2.82 |
Histogen Inc ( F Germany Symbol : CPH1 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CPH1 Business Profile
Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Address: 10655 Sorrento Valley Road, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service